Real life effectiveness and cost impact evaluation of fixed dose combination fluticasone propionate/formoterol (Flutiform®) compared to fluticasone propionate/salmeterol (Seretide®) (eFFectiveness)

First published 02/03/2016

Last updated 23/04/2024

EU PAS number:

EUPAS12631

Study

Finalised

Documents

Study protocol

Initial protocol

150519_R03212c_Napp_Flutiform_switch_study3_protocol_V2.0_AT.compressed

English (1.16 MB - PDF)View document

Study results

R03212c_Statistical_Report_v1

English (1.21 MB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents

Conflicts of interest of investigators

20160302_R03212conflictofinterest

English (95.86 KB - PDF)View document

Composition of steering group and observers

20160302_R03212cSteering Committee

English (107.4 KB - PDF)View document

Secondary tabs